Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retinaklinikken Omnia is a specialized ophthalmic medical center located in Oslo, Norway, focusing on the diagnosis and treatment of vitreoretinal diseases. Originally established within the Omnia Medisinske Senter, the first private hospital in Norway, the clinic provides advanced surgical and medical interventions for conditions such as age-related macular degeneration (AMD), retinal detachment, and diabetic retinopathy. While the parent Omnia group was acquired by Aleris in 2006, the retina clinic has maintained its position as a leading private provider of specialized eye care in the region. The facility utilizes advanced diagnostic imaging and micro-surgical technologies to serve patients as a private alternative to the public hospital system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retinaklinikken Omnia.